Stock comparison
BioMarin Pharmaceutical
BMRN$12.33BHealthcare Market cap, Sector
SANOFI CONS HEALTHC IND L
SANOFICONR.NS$104.11BHealthcare Market cap, Sector
Overall winner
SANOFI CONS HEALTHC IND L
BMRN 07 SANOFICONR.NS
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
BMRN0wins
7winsSANOFICONR.NS
54D
B78
53D
A89
51D
B83
43F
B77
24F
A91
41F
A86
48D
A85
Side-by-side metrics
| Metric | BMRN | SANOFICONR.NS |
|---|---|---|
| Market cap | $12.33B | $104.11B Winner |
| P/E (TTM) | Winner: 38.7x | 44.2x |
| EV/EBIT | Winner: 18.1x | 31.8x |
| ROIC (TTM) | 3.92% | 59.15% Winner |
| Gross margin | Winner: 75.93% | 68.13% |
| Net margin | 8.29% | 27.35% Winner |
| Revenue CAGR 5y | 14.93% | 27.01% Winner |
| EPS CAGR 5y | Winner: 2.29% | 20.67% |
| Debt / Equity | 0.2x | 0.1x Winner |
| Dividend yield | 0.0% | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
BMRN leads on
- EPS CAGR 5y2.29%vs 20.67%+91%
- EV/EBIT18.1xvs 31.8x+43%
- P/E (TTM)38.7xvs 44.2x+12%
- Gross margin75.93%vs 68.13%+10%
SANOFICONR.NS leads on
- ROIC (TTM)59.15%vs 3.92%+93%
- Market cap$104.11Bvs $12.33B+88%
- Debt / Equity0.1xvs 0.2x+72%
- Net margin27.35%vs 8.29%+70%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.